相关实验视频
Updated: Jan 18, 2026

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
28.5K
隐藏的联系:全身免疫炎症指数及其在喘中的作用
Cheng Peng1, Dong Gao2, Zanchen Zhou3
1School of Pharmacy, Anhui University of Chinese Medicine, China.
Clinics (Sao Paulo, Brazil)
|September 7, 2025
概括
较高的全身免疫炎症指数 (SII) 水平与成人喘发病率的增加有关. 这一发现表明SII可能是用于喘风险评估的有用生物标志物.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 喘是一种具有复杂病因的慢性呼吸道疾病.
- 系统性免疫炎症指数 (SII) 反映了系统性炎症.
- 研究喘的新生物标志物对于早期检测和管理至关重要.
研究的目的:
- 探索系统性免疫炎症指数 (SII) 和喘之间的关联.
- 为了确定SII是否可以作为喘发展的预测标记.
主要方法:
- 来自国家健康和营养检查调查 (2015-2020) 数据的分析.
- 使用血小板,中性粒细胞和淋巴细胞计数计算SII.
- 统计方法包括加权多变量回归,子组分析和平滑曲线拟合.
主要成果:
- 分析了13,334名成年人的队列,其中15.34%被诊断患有喘.
- 较高的SII水平与喘发病率的增加显著相关.
- 没有发现与性别,年龄,BMI或并发症等因素的显著相互作用.
结论:
- 系统性免疫炎症指数 (SII) 的升高与患喘的可能性更高有关.
- SII可能代表喘风险的潜在生物标志物.
- 需要进一步的前性研究来验证这些发现.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K

